White Piedra

Total Page:16

File Type:pdf, Size:1020Kb

White Piedra Nosocomial fungal infections – epidemiology, prevention and control © by author Assoc. Prof. Amanda Rădulescu MD., PhD. The “Iuliu Hatieganu” University of Medicine and Pharmacy”ESCMID Cluj-Napoca, Online Romania Lecture Library Etiology – epidemiological characteristics of fungi Microrganisms that are normal commensals, parasites or saprophytes classified according to their appearance by microscopy and in culture, and by the method of reproduction (sexual or asexual). © by author ESCMID Online Lecture Library Clinical groupings for fungal infections Allergies resulting from hipersensitivity to fungal antigens e.g., inhaled fungal spores – Stachybotrys chartarum – “outbreak” of asthma in children, 1997- USA, allergic bronchopulmonary aspergillosis Mycotoxicoses resulting from ingestion of fungal toxins in contaminated food or poisonous mushrooms Mycoses – resulting from invasion of living tissue by a fungus Superficial mycoses - skin, mucous membranes, keratinous tissues - Malassezia furfur - tinea versicolor, candidiasis of the skin, nails, or mucous membranes, Dermatophytoses (ringworm) - Trichophyton spp., Trichosporon beigelii - white piedra Subcutaneous– sporotrichosis - Sporothrix schenkii, mycetoma- Madurella mycetomatis, Pseudollasheria boydii Systemic – deep tissue invasion (histo/cytochemistry showing hyphae or yeast cells from a needle aspiration© by with author evidence of associated tissue damage or positive culture obtained from a normally sterile site consistent with infection, excluding urine) or – fungemia (positive blood cultures of fungi, excluding Aspergillus spp. and Penicillium spp. (other than Penicillium marneffei) accompanied by temporally related clinical signs and symptoms compatible with the ESCMIDrelevant organism). Online Lecture Library Invasive fungal infections Endemic fungal infections (systemic or confined to lungs) Histoplasmosis - Histoplasma capsulatum Coccidiodomycosis - Coccidioides immitis Blastomycosis – Blastomices dermatidis Paracoccidiodomycosis - Paracoccidioides brasiliensis Systemic Candidiasis, systemic - Candida spp. Aspergillosis - Aspergillus spp. Cryptococosis – Cryptococcus neoformans Mucormycosis – Rhizopus,© by Mucor, author Rhizomucor, Absidia Hyalohyphomycosis – Penicillium, Scedosporium, Fusarium Phaeohyphomycosis - Cladosporium, Alternaria Uncommon– Trichosporon spp., Malassezia furfur, Fusarium, dematitiaceous fungi (Alternaria, spp, Cladophialophora, ESCMIDScedosporium, Online Curvularia) Lecture Library Pnecumocystis jiroveci pneumonia Emerging opportunistic yeast infections There has been an overall increase in fungal health care–associated infections (HAIs) in the last decades, a consequence of the advances in medical and surgical therapies More aggressive treatments: – hematopoietic stem cell transplantation (HSCT), – solid organ transplantation (SOT), – new chemotherapeutic© by agents, author and – immunomodulatory agents, has increased the population of immunocompromised patients at risk for invasive fungal infection. ESCMID Online Lecture Library Factors predisposing to fungal infections in patients with cancers Mandel, Douglas and Bennett’s Principles & Practice of Infectious Diseases, 7th ed. 2009 Churchill Livingstone Elsevier Host defense Predisposing factors Fungal pathogens Skin Intravenous and percutaneous Aspergillus spp., Candida spp, M. catheters, total parenteral furfur, Trichosporon spp, Rhizopus nutrition species Gastrointestinal Mucositis, nasogastric tubes, Candida spp., Trichosporon spp. gastrointestinal surgery, antibiotic use Neutrophils, Chemotherapy, hyperglycemia Aspergillus spp., Candida spp, granulocytopenia Mucor, Fusarium, Pseudallescheria boydii, Trichosporon spp. Macrophages Chemotherapy, ©hypergl byycemia author Aspergillus spp., Candida spp, Mucoralles, Histoplasma capsulatum Impaired cellular HIV infection, lymphomas H şi Aspergillus spp. Cryptococcus immunity N-H, corticosteroids neoformans, H. capsulatum, C. ESCMID Online Lectureimmitis, Library P. jiroveci Incidence of systemic fungal infections Accurate data regarding the incidence of systemic mycoses and associated mortality are difficult to obtain due to variable reporting requirements, underdiagnosis, misdiagnosis or not being specified The increasing incidence and attributable mortality of fungal infections were obvious since the last decade of the XXth century representing 3% and 6% of sepsis in United States and Europe, respectively. The incidence: in general population - 8 episodes/100,000 person-year Reese et al. [1998] study performed in San Francisco Bay Area hospitals (45) found 1,600 documented invasive mycoses (1992-1993), incidence ratio of 178 episodes/ 1,000,000 /year,© death by-to author-case rate 22% (90% had serious underlying medical conditions, almost 50% being HIV infected) ICU – 5-10 episodes/1,000 admissions. ESCMID The IVth cause Online of nosocomial Lecture systemic Library infections. Incidence of systemic fungal infections . Fungal infection accounted for 12.3% of all episodes of surgical infection (Raymond et al. Ann Surg 2001) . Fungi accounted for approximately 12.1% of all microbial isolates in their study of severe sepsis among adult admissions to ICUs in Australia and New Zealand (Finfer et al. Intensive Care Med 2006) . the large pan-European Sepsis Occurrence in Acutely Ill Patients (SOAP) study reported fungal infection in 17% of all septic patients in European ICUs (Vincent et al. Crit Care Med 2006) © by author . In a prospective study in ten university surgical ICUs – China, 28.3% of patients with severe sepsis were identified as having IFI with a predominance of 58% Candida albicans) (Guo-Hao XieESCMID et al. Critical CareOnline 2008). Lecture Library Rates of Infectious Complications in Cancer Patients in Studies Published after 2000 – in Mandel, Douglas and Bennett’s Principles & Practice of Infectious Diseases, 7th ed. 2009 Churchill Livingstone Elsevier Episodes/1000 Days at Risk Patient Type of Disease Any Type of Infection or Febrile Bactere Invasive Population Episode mia Mycosis Adults Hematologic malignancies 19.2 4.7 0.7 Children Malignancies 13.3 2.8 0.49 Children Hematologic malignancies, 18.1 5.7 0.27 Children ALL, aggressive treatment — 1.9 0.3 ALL, less aggressive treatment — 0.9 0.1 AnLL, aggressive treatment — 2.7 0.5 Children Solid tumors aggressively treated — 1.1 0.1 Solid tumors less aggressively treated — 0.2 0 Children Aggressive treatment for neuroblastoma — 1.7 0.1 Autologous HSCT for neuroblastoma — 4.3 0 Children Neutropenic AL/NHL, aggressive 31.1 5.1 2.1 treatment © by author Neutropenic AL/NHL, not aggressive 12.8 1.1 0 treatment Neutropenic ST, aggressive treatment 24.7 1.5 0.1 Neutropenic ST, not aggressive 14.7 0.9 0.6 treatmentESCMID Online Lecture Library Neutropenic autologous HSCT 37.8 5.1 0.7 Frequency & Predictors of Mortality in Sepsis Patients. By univariate analysis, Staphylococcus, Pseudomonas species, and C. albicans were © associatedby author with a higher mortality. Jean-Louis Vincent et al. Sepsis in European intensive care units: Results of the SOAP ESCMID OnlineStudy. Lecture Crit Care Med Library 2006 Vol. 34, No. 2 Trends in nosocomial bloodstream infections - USA The study detected 24,179 cases of nosocomial BSI in 49 US hospitals over a 7-year period from March 1995 through September 2002 (60 cases per 10,000 hospital admissions). Gram-positive organisms caused 65% of these BSIs, gram-negative organisms caused 25%, and fungi caused 9.5% (Candida species- 9%). The crude mortality rate was 27%. In neutropenic patients, infections with Candida species, enterococci, and viridans © bygroup author streptococci were significantly more common. Martin GS et al. The epidemiology of sepsis in the United States from 1979 through Wisplinghoff H et al. Clin Infect Dis 2004;39(3):309–17. 2000. N Engl JESCMID Med. 2003; 348: Online1546-54. Lecture Library Trends of IFI - 1991 -2003 in USA © by author (http://www.cdc.gov/nchs/) From Pfaller& ESCMIDDiekema. Clin Microbiol Online Rev 2007; Lecture Library 20:133-63 Incidence rates and distribution of pathogens most commonly isolated from monomicrobial nosocomial bloodstream infections (BSIs) and associated crude mortality rates © by author ESCMIDFrom Online Wisplinghoff Lecture et al. Clin Infect Library Dis 2004;39:309- 317 Time interval between hospital admission and onset of infection for the most frequently isolated pathogens in a series of 24,179 cases of nosocomial bloodstream infection - USA © by author ESCMIDFrom Online Wisplinghoff Lecture et al. Clin Infect Library Dis 2004;39:309- 317 Invasive candidiasis Candida spp. are the most common fungal pathogens causing serious HAIs, especially in patients admitted to intensive care units (ICUs). the incidence rate of invasive candidiasis increased from 23 per 100,000 US population in 1996 to 29 per 100,000 in 2003 (A National Hospital Discharge Survey) Among invasive candidiasis, candidemia is estimated to account for 2 to 8 infections per 10,000 hospital discharges in recent studies from the United States and Europe The true incidence of health care–associated candidemia is likely to be higher because of the relatively poor diagnostic yield (~50%) of positive blood culture results in patients with disseminated candidiasis with implicit candidemia. Matched cohort and case-control studies in various hospitalized patient populations, report attributable© by mortality author rates for candidemia ranging from 5% to 71%. Recent case-control studies based on hospital
Recommended publications
  • Fungal Infections from Human and Animal Contact
    Journal of Patient-Centered Research and Reviews Volume 4 Issue 2 Article 4 4-25-2017 Fungal Infections From Human and Animal Contact Dennis J. Baumgardner Follow this and additional works at: https://aurora.org/jpcrr Part of the Bacterial Infections and Mycoses Commons, Infectious Disease Commons, and the Skin and Connective Tissue Diseases Commons Recommended Citation Baumgardner DJ. Fungal infections from human and animal contact. J Patient Cent Res Rev. 2017;4:78-89. doi: 10.17294/2330-0698.1418 Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes, and the patient experience. REVIEW Fungal Infections From Human and Animal Contact Dennis J. Baumgardner, MD Aurora University of Wisconsin Medical Group, Aurora Health Care, Milwaukee, WI; Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI; Center for Urban Population Health, Milwaukee, WI Abstract Fungal infections in humans resulting from human or animal contact are relatively uncommon, but they include a significant proportion of dermatophyte infections. Some of the most commonly encountered diseases of the integument are dermatomycoses. Human or animal contact may be the source of all types of tinea infections, occasional candidal infections, and some other types of superficial or deep fungal infections. This narrative review focuses on the epidemiology, clinical features, diagnosis and treatment of anthropophilic dermatophyte infections primarily found in North America.
    [Show full text]
  • Coccidioides Immitis
    24/08/2017 FUNGAL AGENTS CAUSING INFECTION OF THE LUNG Microbiology Lectures of the Respiratory Diseases Prepared by: Rizalinda Sjahril Microbiology Department Faculty of Medicine Hasanuddin University 2016 OVERVIEW OF CLINICAL MYCOLOGY . Among 150.000 fungi species only 100-150 are human pathogens 25 spp most common pathogens . Majority are saprophyticLiving on dead or decayed organic matter . Transmission Person to person (rare) SPORE INHALATION OR ENTERS THE TISSUE FROM TRAUMA Animal to person (rare) – usually in dermatophytosis 1 24/08/2017 OVERVIEW OF CLINICAL MYCOLOGY . Human is usually resistant to infection, unless: Immunoscompromised (HIV, DM) Serious underlying disease Corticosteroid/antimetabolite treatment . Predisposing factors: Long term intravenous cannulation Complex surgical procedures Prolonged/excessive antibacterial therapy OVERVIEW OF CLINICAL MYCOLOGY . Several fungi can cause a variety of infections: clinical manifestation and severity varies. True pathogens -- have the ability to cause infection in otherwise healthy individuals 2 24/08/2017 Opportunistic/deep mycoses which affect the respiratory system are: Cryptococcosis Aspergillosis Zygomycosis True pathogens are: Blastomycosis Seldom severe Treatment not required unless extensive tissue Coccidioidomycosis destruction compromising respiratory status Histoplasmosis Or extrapulmonary fungal dissemination Paracoccidioidomycosis COMMON PATHOGENS OBTAINED FROM SPECIMENS OF PATIENTS WITH RESPIRATORY DISEASE Fungi Common site of Mode of Infectious Clinical
    [Show full text]
  • Utility of Miconazole Therapy for Trichosporon Fungemia in Patients with Acute Leukemia
    Advances in Microbiology, 2013, 3, 47-51 Published Online December 2013 (http://www.scirp.org/journal/aim) http://dx.doi.org/10.4236/aim.2013.38A008 Utility of Miconazole Therapy for Trichosporon Fungemia in Patients with Acute Leukemia Kazunori Nakase1,2*, Kei Suzuki2, Taiichi Kyo3, Yumiko Sugawara2, Shinichi Kageyama2, Naoyuki Katayama2 1Cancer Center, Mie University Hospital, Tsu, Japan 2Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan 3Fourth Department of Internal Medicine, Hiroshima Red Cross and Atomic-Bomb Survivors Hospital, Hiroshima, Japan Email: [email protected] Received October 15, 2013; revised November 15, 2013; accepted November 21, 2013 Copyright © 2013 Kazunori Nakase et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Invasive trichosporonosis is an extremely rare mycosis, but Trichosporon fungemia (TF) in patients with hematologic malignancies has been increasingly recognized to be a fulminant and highly lethal infection. Although the utility of az- ole therapy has been demonstrated in several observations, little is known about the efficacy of one of azoles, micona- zole (MCZ). To assess its therapeutic role, we retrospectively investigated 6 cases of TF in patients with acute leukemia receiving MCZ containing regimens. Successful outcome was obtained in 4 patients [MCZ + amphotericin B (AmB) in 2, MCZ only and MCZ + fluconazole (FLCZ) + AmB in one each], but not in 2 (MCZ + FLCZ + AmB and MCZ + FLCZ in one each). Although MCZ and AmB exhibited good in vitro activities against isolates from all patients, FLCZ had such finding from only one patient.
    [Show full text]
  • FINAL RISK ASSESSMENT for Aspergillus Niger (February 1997)
    ATTACHMENT I--FINAL RISK ASSESSMENT FOR Aspergillus niger (February 1997) I. INTRODUCTION Aspergillus niger is a member of the genus Aspergillus which includes a set of fungi that are generally considered asexual, although perfect forms (forms that reproduce sexually) have been found. Aspergilli are ubiquitous in nature. They are geographically widely distributed, and have been observed in a broad range of habitats because they can colonize a wide variety of substrates. A. niger is commonly found as a saprophyte growing on dead leaves, stored grain, compost piles, and other decaying vegetation. The spores are widespread, and are often associated with organic materials and soil. History of Commercial Use and Products Subject to TSCA Jurisdiction The primary uses of A. niger are for the production of enzymes and organic acids by fermentation. While the foods, for which some of the enzymes may be used in preparation, are not subject to TSCA, these enzymes may have multiple uses, many of which are not regulated except under TSCA. Fermentations to produce these enzymes may be carried out in vessels as large as 100,000 liters (Finkelstein et al., 1989). A. niger is also used to produce organic acids such as citric acid and gluconic acid. The history of safe use for A. niger comes primarily from its use in the food industry for the production of many enzymes such as a-amylase, amyloglucosidase, cellulases, lactase, invertase, pectinases, and acid proteases (Bennett, 1985a; Ward, 1989). In addition, the annual production of citric acid by fermentation is now approximately 350,000 tons, using either A.
    [Show full text]
  • Standard Methods for Fungal Brood Disease Research Métodos Estándar Para La Investigación De Enfermedades Fúngicas De La Cr
    Journal of Apicultural Research 52(1): (2013) © IBRA 2013 DOI 10.3896/IBRA.1.52.1.13 REVIEW ARTICLE Standard methods for fungal brood disease research Annette Bruun Jensen1*, Kathrine Aronstein2, José Manuel Flores3, Svjetlana Vojvodic4, María 5 6 Alejandra Palacio and Marla Spivak 1Department of Plant and Environmental Sciences, University of Copenhagen, Thorvaldsensvej 40, 1817 Frederiksberg C, Denmark. 2Honey Bee Research Unit, USDA-ARS, 2413 E. Hwy. 83, Weslaco, TX 78596, USA. 3Department of Zoology, University of Córdoba, Campus Universitario de Rabanales (Ed. C-1), 14071, Córdoba, Spain. 4Center for Insect Science, University of Arizona, 1041 E. Lowell Street, PO Box 210106, Tucson, AZ 85721-0106, USA. 5Unidad Integrada INTA – Facultad de Ciencias Ags, Universidad Nacional de Mar del Plata, CC 276,7600 Balcarce, Argentina. 6Department of Entomology, University of Minnesota, St. Paul, Minnesota 55108, USA. Received 1 May 2012, accepted subject to revision 17 July 2012, accepted for publication 12 September 2012. *Corresponding author: Email: [email protected] Summary Chalkbrood and stonebrood are two fungal diseases associated with honey bee brood. Chalkbrood, caused by Ascosphaera apis, is a common and widespread disease that can result in severe reduction of emerging worker bees and thus overall colony productivity. Stonebrood is caused by Aspergillus spp. that are rarely observed, so the impact on colony health is not very well understood. A major concern with the presence of Aspergillus in honey bees is the production of airborne conidia, which can lead to allergic bronchopulmonary aspergillosis, pulmonary aspergilloma, or even invasive aspergillosis in lung tissues upon inhalation by humans. In the current chapter we describe the honey bee disease symptoms of these fungal pathogens.
    [Show full text]
  • Ringworm & Other Human Fungal Infections
    Ringworm & Other Human Fungal Infections McKenzie Pediatrics Ringworm, medically known as Tinea Corporis, is a common skin infection of childhood, and is not caused by a worm at all, but rather by a fungus. It is usually easily treated, and should not be seen as a source of social stigma. It is just one of many types of Tinea infections that affect humans. Tinea is a widespread group of fungal infections caused by dermatophytes. It is second to acne as the most frequently reported skin disease in the United States. Infection may occur through contact with infected humans (by way of shared combs, brushes, hats, pillows, clothing, or bedding) and animals (especially dogs and cats), soil, or inanimate objects. Tinea should be suspected in any red, scaly, itchy, and enlarging rash. Tinea is a superficial infection of the skin (Tinea Corporis), scalp (Tinea Capitis), nails (Tinea Unguium), groin (Tinea Cruris), hands (Tinea Manuum) or feet (Tinea Pedis). There are three types and 27 varieties of dermatophytes that cause human Tinea: Trichophyton, Epidermophyton, and Microsporum. Tinea Corporis (Ringworm) causes smooth and bare skin, typically surrounded by a raised, red, scaly “ring”. Lesions are often solitary, though may be multiple, and even overlapping. It is not nearly as common as what it is most often mistaken for: nummular eczema, a variety of eczema that causes round or oval scaly patches but without a clear area in the center. Nummular eczema tends to be more numerous, and is often less itchy than Ringworm. Topical treatments that are available over-the-counter usually work quite well for Tinea Corporis.
    [Show full text]
  • Turning on Virulence: Mechanisms That Underpin the Morphologic Transition and Pathogenicity of Blastomyces
    Virulence ISSN: 2150-5594 (Print) 2150-5608 (Online) Journal homepage: http://www.tandfonline.com/loi/kvir20 Turning on Virulence: Mechanisms that underpin the Morphologic Transition and Pathogenicity of Blastomyces Joseph A. McBride, Gregory M. Gauthier & Bruce S. Klein To cite this article: Joseph A. McBride, Gregory M. Gauthier & Bruce S. Klein (2018): Turning on Virulence: Mechanisms that underpin the Morphologic Transition and Pathogenicity of Blastomyces, Virulence, DOI: 10.1080/21505594.2018.1449506 To link to this article: https://doi.org/10.1080/21505594.2018.1449506 © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group© Joseph A. McBride, Gregory M. Gauthier and Bruce S. Klein Accepted author version posted online: 13 Mar 2018. Submit your article to this journal Article views: 15 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=kvir20 Publisher: Taylor & Francis Journal: Virulence DOI: https://doi.org/10.1080/21505594.2018.1449506 Turning on Virulence: Mechanisms that underpin the Morphologic Transition and Pathogenicity of Blastomyces Joseph A. McBride, MDa,b,d, Gregory M. Gauthier, MDa,d, and Bruce S. Klein, MDa,b,c a Division of Infectious Disease, Department of Medicine, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI 53792, USA; b Division of Infectious Disease, Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, 1675 Highland Avenue, Madison, WI 53792, USA; c Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, 1550 Linden Drive, Madison, WI 53706, USA.
    [Show full text]
  • Diagnosis and Treatment of Tinea Versicolor Ronald Savin, MD New Haven, Connecticut
    ■ CLINICAL REVIEW Diagnosis and Treatment of Tinea Versicolor Ronald Savin, MD New Haven, Connecticut Tinea versicolor (pityriasis versicolor) is a common imidazole, has been used for years both orally and top­ superficial fungal infection of the stratum corneum. ically with great success, although it has not been Caused by the fungus Malassezia furfur, this chronical­ approved by the Food and Drug Administration for the ly recurring disease is most prevalent in the tropics but indication of tinea versicolor. Newer derivatives, such is also common in temperate climates. Treatments are as fluconazole and itraconazole, have recently been available and cure rates are high, although recurrences introduced. Side effects associated with these triazoles are common. Traditional topical agents such as seleni­ tend to be minor and low in incidence. Except for keto­ um sulfide are effective, but recurrence following treat­ conazole, oral antifungals carry a low risk of hepato- ment with these agents is likely and often rapid. toxicity. Currently, therapeutic interest is focused on synthetic Key Words: Tinea versicolor; pityriasis versicolor; anti­ “-azole” antifungal drugs, which interfere with the sterol fungal agents. metabolism of the infectious agent. Ketoconazole, an (J Fam Pract 1996; 43:127-132) ormal skin flora includes two morpho­ than formerly thought. In one study, children under logically discrete lipophilic yeasts: a age 14 represented nearly 5% of confirmed cases spherical form, Pityrosporum orbicu- of the disease.3 In many of these cases, the face lare, and an ovoid form, Pityrosporum was involved, a rare manifestation of the disease in ovale. Whether these are separate enti­ adults.1 The condition is most prevalent in tropical tiesN or different morphologic forms in the cell and semitropical areas, where up to 40% of some cycle of the same organism remains unclear.: In the populations are affected.
    [Show full text]
  • (Sporanox Capsules) 280-A
    PRIOR AUTHORIZATION CRITERIA BRAND NAME (generic) SPORANOX ORAL CAPSULES (itraconazole) Status: CVS Caremark Criteria Type: Initial Prior Authorization Policy FDA-APPROVED INDICATIONS Sporanox (itraconazole) Capsules are indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: 1. Blastomycosis, pulmonary and extrapulmonary 2. Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis, and 3. Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy. Specimens for fungal cultures and other relevant laboratory studies (wet mount, histopathology, serology) should be obtained before therapy to isolate and identify causative organisms. Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, antiinfective therapy should be adjusted accordingly. Sporanox Capsules are also indicated for the treatment of the following fungal infections in non-immunocompromised patients: 1. Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium), and 2. Onychomycosis of the fingernail due to dermatophytes (tinea unguium). Prior to initiating treatment, appropriate nail specimens for laboratory testing (KOH preparation, fungal culture, or nail biopsy) should be obtained to confirm the diagnosis of onychomycosis. Compendial Uses Coccidioidomycosis2,3
    [Show full text]
  • Allergic Bronchopulmonary Aspergillosis and Severe Asthma with Fungal Sensitisation
    Allergic Bronchopulmonary Aspergillosis and Severe Asthma with Fungal Sensitisation Dr Rohit Bazaz National Aspergillosis Centre, UK Manchester University NHS Foundation Trust/University of Manchester ~ ABPA -a41'1 Severe asthma wl'th funga I Siens itisat i on Subacute IA Chronic pulmonary aspergillosjs Simp 1Ie a:spe rgmoma As r§i · bronchitis I ram une dysfu net Ion Lun· damage Immu11e hypce ractivitv Figure 1 In t@rarctfo n of Aspergillus Vliith host. ABP A, aHerg tc broncho pu~ mo na my as µe rgi ~fos lis; IA, i nvas we as ?@rgiH os 5. MANCHl·.'>I ER J:-\2 I Kosmidis, Denning . Thorax 2015;70:270–277. doi:10.1136/thoraxjnl-2014-206291 Allergic Fungal Airway Disease Phenotypes I[ Asthma AAFS SAFS ABPA-S AAFS-asthma associated with fu ngaIsensitization SAFS-severe asthma with funga l sensitization ABPA-S-seropositive a llergic bronchopulmonary aspergi ll osis AB PA-CB-all ergic bronchopulmonary aspergi ll osis with central bronchiectasis Agarwal R, CurrAlfergy Asthma Rep 2011;11:403 Woolnough K et a l, Curr Opin Pulm Med 2015;21:39 9 Stanford Lucile Packard ~ Children's. Health Children's. Hospital CJ Scanford l MEDICINE Stanford MANCHl·.'>I ER J:-\2 I Aspergi 11 us Sensitisation • Skin testing/specific lgE • Surface hydroph,obins - RodA • 30% of patients with asthma • 13% p.atients with COPD • 65% patients with CF MANCHl·.'>I ER J:-\2 I Alternar1a• ABPA •· .ABPA is an exagg·erated response ofthe imm1une system1 to AspergUlus • Com1pUcatio n of asthm1a and cystic f ibrosis (rarell·y TH2 driven COPD o r no identif ied p1 rior resp1 iratory d isease) • ABPA as a comp1 Ucation of asth ma affects around 2.5% of adullts.
    [Show full text]
  • Trichosporon Beigelii Infection Presenting As White Piedra and Onychomycosis in the Same Patient
    Trichosporon beigelii Infection Presenting as White Piedra and Onychomycosis in the Same Patient Lt Col Kathleen B. Elmer, USAF; COL Dirk M. Elston, MC, USA; COL Lester F. Libow, MC, USA Trichosporon beigelii is a fungal organism that causes white piedra and has occasionally been implicated as a nail pathogen. We describe a patient with both hair and nail changes associated with T beigelii. richosporon beigelii is a basidiomycetous yeast, phylogenetically similar to Cryptococcus.1 T T beigelii has been found on a variety of mammals and is present in soil, water, decaying plants, and animals.2 T beigelii is known to colonize normal human skin, as well as the respiratory, gas- trointestinal, and urinary tracts.3 It is the causative agent of white piedra, a superficial fungal infection of the hair shaft and also has been described as a rare cause of onychomycosis.4 T beigelii can cause endo- carditis and septicemia in immunocompromised hosts.5 We describe a healthy patient with both white piedra and T beigelii–induced onychomycosis. Case Report A 62-year-old healthy man who worked as a pool maintenance employee was evaluated for thickened, discolored thumb nails (Figure 1). He had been aware of progressive brown-to-black discoloration of the involved nails for 8 months. In addition, soft, light yellow-brown nodules were noted along the shafts of several axillary hairs (Figure 2). Microscopic analysis of the hairs revealed nodal concretions along the shafts (Figure 3). No pubic, scalp, eyebrow, eyelash, Figure 1. Onychomycotic thumb nail. or beard hair involvement was present. Cultures of thumb nail clippings on Sabouraud dextrose agar grew T beigelii and Candida parapsilosis.
    [Show full text]
  • Histopathology of Important Fungal Infections
    Journal of Pathology of Nepal (2019) Vol. 9, 1490 - 1496 al Patholo Journal of linic gist C of of N n e o p ti a a l- u i 2 c 0 d o n s 1 s 0 a PATHOLOGY A m h t N a e K , p d of Nepal a l a M o R e d n i io ca it l A ib ss xh www.acpnepal.com oc g E iation Buildin Review Article Histopathology of important fungal infections – a summary Arnab Ghosh1, Dilasma Gharti Magar1, Sushma Thapa1, Niranjan Nayak2, OP Talwar1 1Department of Pathology, Manipal College of Medical Sciences, Pokhara, Nepal. 2Department of Microbiology, Manipal College of Medical Sciences , Pokhara, Nepal. ABSTRACT Keywords: Fungus; Fungal infections due to pathogenic or opportunistic fungi may be superficial, cutaneous, subcutaneous Mycosis; and systemic. With the upsurge of at risk population systemic fungal infections are increasingly common. Opportunistic; Diagnosis of fungal infections may include several modalities including histopathology of affected tissue Systemic which reveal the morphology of fungi and tissue reaction. Fungi can be in yeast and / or hyphae forms and tissue reactions may range from minimal to acute or chronic granulomatous inflammation. Different fungi should be differentiated from each other as well as bacteria on the basis of morphology and also clinical correlation. Special stains like GMS and PAS are helpful to identify fungi in tissue sections. INTRODUCTION Correspondence: Dr Arnab Ghosh, MD Fungal infections or mycoses may be caused by Department of Pathology, pathogenic fungi which infect healthy individuals or by Manipal College of Medical Sciences, Pokhara, Nepal.
    [Show full text]